Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-06 Sale |
2023-01-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,284 | $25.98 | $267,203 | 265,716 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $26.4 | $59,405 | 152,639 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $27.07 | $406,076 | 463,381 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $29.43 | $60,591 | 205,577 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $28.43 | $397,193 | 148,243 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-12 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $22.74 | $236,310 | 415,666 (Direct) |
View |
| 2022-12-07 Sale |
2022-12-09 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $21.85 | $516,782 | 210,111 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,000 | $17.67 | $706,772 | 288,453 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $17.38 | $39,114 | 154,889 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 7:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $18 | $270,000 | 478,381 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 7:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $19.06 | $1,620 | 98,253 (Direct) |
View |
| 2022-11-23 Sale |
2022-11-28 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $19.07 | $24,048 | 98,338 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 8:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $19.43 | $20,151 | 295,227 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $18.87 | $415,085 | 777,996 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
26,000 | $18.24 | $474,351 | 635,422 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $19.2 | $43,194 | 157,139 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
1,038 | $19.5 | $20,241 | 0 (Direct) |
View |
| 2022-11-02 Sale |
2022-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus SENIOR VICE PRESIDENT, CMC |
1,130 | $18.89 | $21,346 | 0 (Direct) |
View |
| 2022-10-18 Sale |
2022-10-20 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
5,705 | $21.08 | $120,287 | 299,166 (Direct) |
View |
| 2022-10-14 Sale |
2022-10-18 5:01 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,295 | $20.16 | $86,585 | 613,927 (Direct) |
View |
| 2022-10-10 Sale |
2022-10-12 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,954 | $16.89 | $83,681 | 309,166 (Direct) |
View |
| 2022-10-06 Sale |
2022-10-11 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
23,560 | $15.91 | $374,803 | 716,045 (Direct) |
View |
| 2022-10-05 Sale |
2022-10-07 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $15.75 | $35,447 | 159,389 (Direct) |
View |
| 2022-09-12 Sale |
2022-09-14 5:15 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,520 | $17.33 | $130,307 | 36,900 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 5:30 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
7,840 | $17.8 | $139,584 | 108,310 (Direct) |
View |
| 2022-09-06 Sale |
2022-09-08 5:30 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
12,829 | $18.5 | $237,345 | 82,476 (Direct) |
View |
| 2022-09-06 Sale |
2022-09-07 5:30 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
2,250 | $19 | $42,750 | 161,639 (Direct) |
View |
| 2022-08-18 Sale |
2022-08-19 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
2,250 | $21.18 | $47,657 | 163,889 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
21,000 | $23 | $482,932 | 69,908 (Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 5:15 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
14,067 | $24.07 | $338,598 | 38,513 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-10 5:15 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
15,643 | $24.31 | $380,287 | 74,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-19 Option Award |
2023-01-23 6:02 pm |
N/A 2033-01-18 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
2,519 | $15.48 | 27,519 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:02 pm |
N/A 2033-01-18 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
25,000 | $0 | 27,519 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,871 | $2.14 | 265,716 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,001 | $0 | 265,716 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 265,716 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 152,639 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 152,639 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 152,639 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
2,654 | $18.08 | 2,654 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
2,627 | $18.08 | 2,627 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 463,381 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 463,381 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $2.14 | 205,577 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,059 | $0 | 205,577 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $2.14 | 148,243 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
13,969 | $0 | 148,243 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $2.14 | 415,666 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-12 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,394 | $0 | 415,666 (Direct) |
View |
| 2022-12-07 Exercise |
2022-12-09 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $2.14 | 210,111 (Direct) |
View |
| 2022-12-07 Exercise |
2022-12-09 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
23,648 | $0 | 210,111 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
37,588 | $2.14 | 288,453 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
40,000 | $0 | 288,453 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 288,453 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 154,889 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 154,889 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 154,889 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $2.14 | 478,381 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
15,000 | $0 | 478,381 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-02 7:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $2.14 | 98,253 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-02 7:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
85 | $0 | 98,253 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $2.14 | 98,338 (Direct) |
View |
| 2022-11-23 Exercise |
2022-11-28 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,261 | $0 | 98,338 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 8:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $2.14 | 295,227 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-22 8:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
1,037 | $0 | 295,227 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $2.14 | 777,996 (Direct) |
View |
| 2022-11-09 Exercise |
2022-11-14 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,998 | $0 | 777,996 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
23,587 | $2.14 | 635,422 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
25,999 | $0 | 635,422 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 635,422 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 157,139 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 157,139 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 157,139 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
5,705 | $2.14 | 299,166 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
5,705 | $0 | 299,166 (Direct) |
View |
| 2022-10-14 Exercise |
2022-10-18 5:01 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,295 | $2.14 | 613,927 (Direct) |
View |
| 2022-10-14 Exercise |
2022-10-18 5:01 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,295 | $0 | 613,927 (Direct) |
View |
| 2022-10-10 Exercise |
2022-10-12 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,954 | $2.14 | 309,166 (Direct) |
View |
| 2022-10-10 Exercise |
2022-10-12 5:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
4,954 | $0 | 309,166 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-11 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
21,149 | $2.14 | 716,045 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-11 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
23,560 | $0 | 716,045 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-11 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,411 | $1.74 | 716,045 (Direct) |
View |
| 2022-10-05 Exercise |
2022-10-07 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,600 | $2.14 | 159,389 (Direct) |
View |
| 2022-10-05 Exercise |
2022-10-07 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
2,250 | $0 | 159,389 (Direct) |
View |
| 2022-10-05 Exercise |
2022-10-07 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
650 | $1.74 | 159,389 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 5:15 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,520 | $2.14 | 36,900 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 5:15 pm |
N/A 2031-04-02 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,520 | $0 | 36,900 (Direct) |
View |
| 2022-09-09 Exercise |
2022-09-12 5:30 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
4,462 | $2.14 | 108,310 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 5:30 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
7,840 | $0 | 108,310 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 5:30 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
3,378 | $1.74 | 108,310 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-08 5:30 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
17,386 | $0 | 82,476 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-08 5:30 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
17,386 | $1.74 | 82,476 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-07 5:30 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
1,600 | $2.14 | 161,639 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-07 5:30 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
2,250 | $0 | 161,639 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-07 5:30 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
650 | $1.74 | 161,639 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-19 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
1,600 | $2.14 | 163,889 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-19 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
2,250 | $0 | 163,889 (Direct) |
View |
| 2022-08-18 Exercise |
2022-08-19 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer |
650 | $1.74 | 163,889 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 5:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
21,000 | $0 | 69,908 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 5:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
21,000 | $1.74 | 69,908 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 5:15 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
14,067 | $0 | 38,513 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 5:15 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
14,067 | $1.74 | 38,513 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 5:15 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
15,643 | $0 | 74,000 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 5:15 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T See Remarks |
15,643 | $1.74 | 74,000 (Direct) |
View |
| 2022-07-15 Other |
2022-07-19 5:28 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Atlas Venture Fund XII L.P. 10% Owner |
310,388 | $0 | 2,638,297 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:01 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | Resnick Joshua Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |